Korean J Urol Oncol.  2022 Feb;20(1):52-58. 10.22465/kjuo.2022.20.1.52.

Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer

Affiliations
  • 1Department of Urology, Dongnam Institite of Radiological & Medical Sciences, Busan, Korea
  • 2Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
  • 3Department of Urology, Chonnam National University Medical School, Gwangju, Korea
  • 4Department of Urology, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
  • 5Department of Urology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea

Abstract

Purpose
The aims of this study were to investigate the clinical value of Rab27a as a urinary biomarker, and its efficiency in the prediction of bladder cancer grade.
Materials and Methods
The expression of Rab27a in urine samples of patients with bladder cancer, cell line (T-24), and tissue samples of patients with bladder cancer was estimated via quantitative reverse transcription polymerase chain reaction (qRT-PCR). The Rab27a expression level was investigated according to sex, age, and histological grade via qRT-PCR and Western blotting.
Results
Rab27a was also expressed at high levels in urine compared to cell lines and tissues from bladder cancer patients. In addition, Rab27a expression varied significantly according to tumor grade (p<0.001). Rab27a was expressed at high levels in male and elderly patients, however, there was not statistically significant.
Conclusions
Our results indicated that Rab27a is valuable as a urinary diagnostic biomarker for bladder cancer. In addition, it may serve as a predictive factor for determining bladder cancer grade.

Keyword

Biomarker; Liquid biopsy; Rab27a; Urinary bladder neoplasms; Urine
Full Text Links
  • KJUO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr